Time to initiation of oral antihyperglycemic and statin therapy in previously untreated patients with type 2 diabetes in the United States
作者： Peter Sun , Kaan Tunceli , Qiaoyi Zhang , Thomas Seck , Kristy Iglay
DOI: 10.1185/03007995.2013.800473
关键词:
摘要: AbstractObjective:To assess the time from first observed diagnosis of type 2 diabetes (T2DM) to initiation an oral antihyperglycemic agent (OAHA) and statin.Methods:In a retrospective US cohort study using GE electronic medical record database, patients ≥18 years were included if they had T2DM between January 1, 2004 December 31, 2005 (index period), last pre-index HbA1c value ≥7%, not received agents within one year prior date). Patients eligible for statin therapy but on before index date. records (baseline) two after (follow up) diagnosis.Results:Of 2254 patients, 58% male, mean age was 58 years, 8.5%, LDL cholesterol 115 mg/dL (2.97 mmol/L) at baseline. Additionally, 21% pre-existing overt cardiovascular disease, 40% dyslipidemia, 37% obese, 11% smokers. D...
informahealthcare.com参考文章(32)
Larry Radican, Thomas Seck, Changgeng Zhao, Qiaoyi Zhang, Michael J Davies, Compliance and persistence with concomitant statin and oral antihyperglycemic therapy. The American Journal of Managed Care. ,vol. 17, pp. 746- 752 ,(2011)
Devin M Mann, Mark Woodward, Fen Ye, Marie Krousel-Wood, Paul Muntner, Trends in Medication Use Among US Adults With Diabetes Mellitus: Glycemic Control at the Expense of Controlling Cardiovascular Risk Factors Archives of Internal Medicine. ,vol. 169, pp. 1718- 1725 ,(2009) , 10.1001/ARCHINTERNMED.2009.296
Alex Z Fu, Qiaoyi Zhang, Michael J Davies, Sri-Ram Pentakota, Larry Radican, Thomas Seck, None, Underutilization of statins in patients with type 2 diabetes in US clinical practice: a retrospective cohort study Current Medical Research and Opinion. ,vol. 27, pp. 1035- 1040 ,(2011) , 10.1185/03007995.2011.567257
Q. Zhang, S. Rajagopalan, E. Marrett, M. J. Davies, L. Radican, S. S. Engel, Time to treatment initiation with oral antihyperglycaemic therapy in US patients with newly diagnosed type 2 diabetes. Diabetes, Obesity and Metabolism. ,vol. 14, pp. 149- 154 ,(2012) , 10.1111/J.1463-1326.2011.01498.X
Jennifer LY Tsang, Aurora Mendelsohn, Mary KK Tan, Daniel G Hackam, Lawrence A Leiter, David Fitchett, Peter J Lin, Etienne Grima, Anatoly Langer, Shaun G Goodman, Vascular Protection Registry, Guidelines Oriented Approach to Lipid Lowering Registry Investigators, Discordance between physicians' estimation of patient cardiovascular risk and use of evidence-based medical therapy. American Journal of Cardiology. ,vol. 102, pp. 1142- 1145 ,(2008) , 10.1016/J.AMJCARD.2008.06.037
Albert G. Crawford, Christine Cote, Joseph Couto, Mehmet Daskiran, Candace Gunnarsson, Kara Haas, Sara Haas, Somesh C. Nigam, Rob Schuette, Joseph Yaskin, Comparison of GE Centricity Electronic Medical Record Database and National Ambulatory Medical Care Survey Findings on the Prevalence of Major Conditions in the United States Population Health Management. ,vol. 13, pp. 139- 150 ,(2010) , 10.1089/POP.2009.0036
C.Noel Bairey Merz, John B Buse, Diane Tuncer, Gwen B Twillman, Physician attitudes and practices and patient awareness of the cardiovascular complications of diabetes. Journal of the American College of Cardiology. ,vol. 40, pp. 1877- 1881 ,(2002) , 10.1016/S0735-1097(02)02529-9
Peter Sun, Ruoping Wang, Scott Jacober, The effectiveness of insulin initiation regimens in patients with type 2 diabetes mellitus: a large national medical records review study comparing a basal insulin analogue to premixed insulin Current Medical Research and Opinion. ,vol. 23, pp. 3017- 3023 ,(2007) , 10.1185/030079907X242845
J. Stamler, O. Vaccaro, J. D. Neaton, D. Wentworth, , Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. ,vol. 16, pp. 434- 444 ,(1993) , 10.2337/DIACARE.16.2.434
Patricia M Kearney, Anthony Keech, John Simes, Rory Collins, Colin Baigent, None, Statins and diabetes – Authors' reply The Lancet. ,vol. 371, pp. 1752- 1752 ,(2008) , 10.1016/S0140-6736(08)60761-8